Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vasculitis and liver disease].

H C Spangenberg1, H E Blum

  • 1Medizinische Universitätsklinik, Abteilung Innere Medizin II, Albert-Ludwigs-Universität Freiburg. spangenberg@ukl.uni-freiburg.de

Praxis
|October 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.

Cell death and differentiation·2015
Same author

Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' reply.

Alimentary pharmacology & therapeutics·2014
Same author

Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.

Alimentary pharmacology & therapeutics·2014
Same author

[Stimulus-triggered acquisition of pluripotency: a new perspective in reprogramming of differentiated somatic cells].

Deutsche medizinische Wochenschrift (1946)·2014
Same author

[Sofosbuvir: alternative in hepatitis C infection?].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

Reforming the EU environment for clinical trials: what are the challenges?

QJM : monthly journal of the Association of Physicians·2013
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Extrahepatic manifestations, including vasculitis, can occur with hepatitis B (HBV) and hepatitis C (HCV) infections. Treatment for these viral hepatitis complications involves antivirals and immunosuppressants.

Area of Science:

  • Hepatology and Immunology
  • Infectious Diseases
  • Rheumatology

Context:

  • Extrahepatic manifestations are potential complications of acute and chronic viral hepatitis.
  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are associated with diverse systemic symptoms beyond liver disease.
  • These manifestations can include hematological disorders, vasculitis, and serum-like illness.

Purpose:

  • To review the extrahepatic manifestations of HBV and HCV infections.
  • To highlight the association between viral hepatitis and vasculitis, specifically cryoglobulinemic vasculitis (HCV) and polyarteritis nodosa (HBV).
  • To discuss the clinical presentation and therapeutic approaches for these conditions.

Summary:

  • Viral hepatitis, particularly HBV and HCV, can lead to systemic illness including fever, arthralgia, urticaria, bone marrow suppression, and cryoglobulinemia.

Related Experiment Videos

  • HCV is linked to cryoglobulinemic vasculitis presenting with purpura, arthritis, neuropathy, glomerulonephritis, and fatigue.
  • HBV infection is frequently associated with polyarteritis nodosa due to immune complex deposition in arterial walls.

    • Impact:

    • Understanding these associations is crucial for comprehensive patient management.
    • Early recognition and diagnosis of extrahepatic manifestations can guide appropriate treatment strategies.
    • Therapeutic options include antiviral medications and immunosuppressive agents, tailored to disease severity.